Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Interest & Investment Income: 2021-2024

Historic Interest & Investment Income for Foghorn Therapeutics (FHTX) over the last 4 years, with Dec 2024 value amounting to $11.9 million.

  • Foghorn Therapeutics' Interest & Investment Income fell 41.86% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year decrease of 11.65%. This contributed to the annual value of $11.9 million for FY2024, which is 9.43% up from last year.
  • Per Foghorn Therapeutics' latest filing, its Interest & Investment Income stood at $11.9 million for FY2024, which was up 9.43% from $10.9 million recorded in FY2023.
  • In the past 5 years, Foghorn Therapeutics' Interest & Investment Income ranged from a high of $11.9 million in FY2024 and a low of $59,000 during FY2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $10.9 million (2023), whereas its average is $9.5 million.
  • Data for Foghorn Therapeutics' Interest & Investment Income shows a peak YoY soared of 9,518.64% (in 2022) over the last 5 years.
  • Over the past 4 years, Foghorn Therapeutics' Interest & Investment Income (Yearly) stood at $59,000 in 2021, then surged by 9,518.64% to $5.7 million in 2022, then surged by 91.63% to $10.9 million in 2023, then climbed by 9.43% to $11.9 million in 2024.